Boston Scientific (BSX) Revenue Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.59% |
| Dec 31, 2025 | 14.30% |
| Sep 30, 2025 | 13.76% |
| Jun 30, 2025 | 20.37% |
| Mar 31, 2025 | 12.89% |
| Dec 31, 2024 | 9.45% |
| Sep 30, 2024 | 9.23% |
| Jun 30, 2024 | 9.38% |
| Mar 31, 2024 | 9.11% |
| Dec 31, 2023 | 7.78% |
| Sep 30, 2023 | 8.07% |
| Jun 30, 2023 | 7.65% |
| Mar 31, 2023 | 7.33% |
| Dec 31, 2022 | 6.13% |
| Sep 30, 2022 | 7.37% |
| Jun 30, 2022 | 7.53% |
| Mar 31, 2022 | 6.98% |
| Dec 31, 2021 | 7.37% |
| Sep 30, 2021 | 6.85% |
| Jun 30, 2021 | 7.67% |
| Mar 31, 2021 | 6.98% |
| Dec 31, 2020 | 6.49% |
| Sep 30, 2020 | 7.09% |
| Jun 30, 2020 | 1.68% |
| Mar 31, 2020 | 7.54% |
| Dec 31, 2019 | 9.00% |
| Sep 30, 2019 | 7.96% |
| Jun 30, 2019 | 7.03% |
| Mar 31, 2019 | 7.04% |
| Dec 31, 2018 | 6.86% |
| Sep 30, 2018 | 6.64% |
| Jun 30, 2018 | 6.60% |
| Mar 31, 2018 | 6.20% |
| Dec 31, 2017 | 5.75% |
| Sep 30, 2017 | 5.07% |
| Jun 30, 2017 | 4.31% |
| Mar 31, 2017 | 2.97% |
| Dec 31, 2016 | 3.46% |
| Sep 30, 2016 | 2.35% |
| Jun 30, 2016 | 1.48% |
| Mar 31, 2016 | 0.40% |
| Dec 31, 2015 | -0.24% |
| Sep 30, 2015 | -0.29% |
| Jun 30, 2015 | -0.90% |
| Mar 31, 2015 | -2.04% |
| Dec 31, 2014 | -1.92% |
| Sep 30, 2014 | -1.83% |
| Jun 30, 2014 | -2.02% |
| Mar 31, 2014 | -2.47% |